ArticleSurgical endoscopy2026
Comparative study of robot-assisted versus laparoscopic surgery for rectovestibular fistula.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectiveTo compare perioperative outcomes and 30-day complications between robot-assisted anorectoplasty (RAARP) and laparoscopic-assisted anorectoplasty (LAARP) for rectovestibular fistula (RVF), and exploratorily assess bowel function and operative time trends after RAARP. Comparative evidence specific to RVF remains limited.
methodsThis single-center retrospective cohort included 63 patients treated during 2019-2024. Given nonrandom treatment and differing enrollment periods, the primary analysis used the contemporaneous 2021-2024 cohort (RAARP, n = 25; LAARP, n = 23). Propensity scores were estimated by Firth bias-reduced logistic regression including calendar year, and overlap weighting estimated the average treatment effect in the overlap population. The primary outcome was total operative time. Core operative time excluded robotic docking time; for LAARP, it equaled total operative time. Thirty-day complications and Krickenbeck bowel function were analyzed exploratorily.
resultsRAARP was associated with longer total operative time (overlap-weighted difference, 18.00 min; 95% CI 9.90 - 26.10; P < 0.001) but shorter core operative time (- 6.81 min; 95% CI - 10.36 to - 3.26; P < 0.001). Docking time averaged 26.24±11.29 min. Postoperative length of stay did not differ significantly (- 0.53 days; 95% CI - 1.52 to 0.46; P = 0.290). Thirty-day complications did not clearly differ, and no fistula recurred. Within the RAARP group, case sequence correlated negatively with total, docking, and core operative times (Spearman ρ = - 0.987, - 0.975, and - 0.896; all P < 0.001). Among 33 patients with complete Krickenbeck assessments, soiling was less frequent after RAARP [1/12 (8.3%) vs 10/21 (47.6%); exploratory P = 0.027], but missing and non-contemporaneous data limited interpretation.
conclusionsRAARP had shorter core but longer total operative time because of robotic docking. Operative times decreased across consecutive RAARP cases, although no proficiency threshold was estimated. Functional findings remain exploratory.
Indexed as
Identifiers
42834182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.